Share

ApoE4 Carriers: Can These New Therapies Delay or Prevent Alzheimer’s?

Fresh from the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (April 2025)

4 min read
ApoE4 Carriers: Can These New Therapies Delay or Prevent Alzheimer’s?
Evidence-Backed

ApoE4 Carriers: Can These New Therapies Delay or Prevent Alzheimer’s?

Fresh from the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (April 2025)

Hi friends,

In this video, I break down some of the most important findings from the April 2025 international Conference on Alzheimer's and Parkinson's diseases, with direct takeaways for anyone carrying the ApoE4 gene:

  1. The ApoE4 Ancestral Puzzle - Genetics, Lipids, and Global Alzheimer’s Risk

  2. Beyond the Brain - The Liver’s Surprising Role in ApoE4’s Impact

  3. Good vs. Bad ApoE - Protective Variants

  4. ApoE4’s Cellular Effect - How It Disrupts Our Brain Cells

  5. Innovative Therapies on the Horizon

This is part a video series where I dissect all the latest research updates that happened at
1) The Alzheimer’s Association International Conference on APOE and Lipid Biology (March 2025)
2) AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (April 2025)

If you like it, please remember to hit subscribe and hit the notification bell on Youtube so you don’t miss any of my future videos.

Feel free to reply to this email if you have any questions or comments, I read all the emails myself :)

Free Weekly Newsletter

Get Weekly Protocols

Join + readers getting evidence-based APOE4 strategies.

Weekly protocols
Research updates
No spam

Categories

Written by

Phoenix Team

Phoenix Team is a contributor to the APOE4 Blog, sharing evidence-based insights for the APOE4 community.

More from Phoenix
Keep Reading

Related Articles

More about Research